CompletedNot Applicable

Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners

United States14 participantsStarted 2017-12-06

Plain-language summary

This pilot clinical trial studies how well acceptance and commitment therapy works in improving well-being in patients with stage III-IV cancer and their partners. Learning how to accept negative thoughts and feelings and how to live in the present without worrying about the future or past may improve coping skills in patients with stage III-IV cancer and their partners.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosed with stage 3 or 4 breast, cervical, colorectal, endometrial, hepatobiliary, lung, melanoma, gynecological, prostate cancer in the past six months * Married or cohabiting with a significant other of either gender for more than one year * At the time of recruitment, a life expectancy of greater than 6 months and/or a Karnofsky performance status of 80 or above or an Eastern Cooperative Oncology Group (ECOG) score of 0 or 1 * English speaking * No significant hearing impairment that would prevent participation in sessions * Live within a 1 hour commuting distance from Rutgers Cancer Institute of New Jersey Exclusion Criteria: * Partner cannot have cancer diagnosis (other than non-melanoma skin cancer) and be currently receiving treatment

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Change in acceptance as measured by the COPE acceptance subscale

Timeframe: Baseline to 1-week post intervention

Change in avoidance as measured by the Acceptance and Action Questionnaire-II

Timeframe: Baseline to 1-week post intervention

Change in value based living as measured by the Valued Living questionnaire

Timeframe: Baseline to 1-week post intervention

Feasibility defined as acceptance

Timeframe: Up to 1-week post intervention

Feasibility defined as session drop out

Timeframe: Up to 1-week post intervention

Feasibility defined as survey follow ups

Timeframe: Up to 1-week post intervention

Trial details

NCT IDNCT03112668

SponsorRutgers, The State University of New Jersey

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-01-25

View on ClinicalTrials.gov More Malignant Female Reproductive System Neoplasm trials

Plain-language summary

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Change in acceptance as measured by the COPE acceptance subscale

Timeframe: Baseline to 1-week post intervention

Change in avoidance as measured by the Acceptance and Action Questionnaire-II

Timeframe: Baseline to 1-week post intervention

Change in value based living as measured by the Valued Living questionnaire

Timeframe: Baseline to 1-week post intervention

Feasibility defined as acceptance

Timeframe: Up to 1-week post intervention

Feasibility defined as session drop out

Timeframe: Up to 1-week post intervention

Feasibility defined as survey follow ups

Timeframe: Up to 1-week post intervention